202 related articles for article (PubMed ID: 38839835)
1. A reanalysis and integration of transcriptomics and proteomics datasets unveil novel drug targets for Mekong schistosomiasis.
Thawornkuno C; Srisuksai K; Simanon N; Adisakwattana P; Ampawong S; Boonyuen U; Limpanont Y; Chusongsang P; Chusongsang Y; Kiangkoo N; Reamtong O
Sci Rep; 2024 Jun; 14(1):12969. PubMed ID: 38839835
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel.
Chienwichai P; Tipthara P; Tarning J; Limpanont Y; Chusongsang P; Chusongsang Y; Adisakwattana P; Reamtong O
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009706. PubMed ID: 34473691
[TBL] [Abstract][Full Text] [Related]
3. Identification of Low Molecular Weight Proteins and Peptides from
Thiangtrongjit T; Simanon N; Adisakwattana P; Limpanont Y; Chusongsang P; Chusongsang Y; Reamtong O
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33920436
[No Abstract] [Full Text] [Related]
4. Proteomic analysis of adult Schistosoma mekongi somatic and excretory-secretory proteins.
Reamtong O; Simanon N; Thiangtrongjit T; Limpanont Y; Chusongsang P; Chusongsang Y; Anuntakarun S; Payungporn S; Phuphisut O; Adisakwattana P
Acta Trop; 2020 Feb; 202():105247. PubMed ID: 31672487
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analysis of reduced sensitivity to praziquantel in Schistosoma mansoni.
Sanchez MC; Cupit PM; Bu L; Cunningham C
Mol Biochem Parasitol; 2019 Mar; 228():6-15. PubMed ID: 30658180
[TBL] [Abstract][Full Text] [Related]
6. Re-positioning protein-kinase inhibitors against schistosomiasis.
Gelmedin V; Dissous C; Grevelding CG
Future Med Chem; 2015; 7(6):737-52. PubMed ID: 25996067
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic analysis of male and female Schistosoma mekongi adult worms.
Phuphisut O; Ajawatanawong P; Limpanont Y; Reamtong O; Nuamtanong S; Ampawong S; Chaimon S; Dekumyoy P; Watthanakulpanich D; Swierczewski BE; Adisakwattana P
Parasit Vectors; 2018 Sep; 11(1):504. PubMed ID: 30201055
[TBL] [Abstract][Full Text] [Related]
8. Phosphoproteomics analysis of male and female Schistosoma mekongi adult worms.
Simanon N; Adisakwattana P; Thiangtrongjit T; Limpanont Y; Chusongsang P; Chusongsang Y; Anuntakarun S; Payungporn S; Ampawong S; Reamtong O
Sci Rep; 2019 Jul; 9(1):10012. PubMed ID: 31292487
[TBL] [Abstract][Full Text] [Related]
9. Protein kinases as potential targets for novel anti-schistosomal strategies.
Beckmann S; Leutner S; Gouignard N; Dissous C; Grevelding CG
Curr Pharm Des; 2012; 18(24):3579-94. PubMed ID: 22607148
[TBL] [Abstract][Full Text] [Related]
10. Protein Kinases: Potential Drug Targets Against
Wu K; Zhai X; Huang S; Jiang L; Yu Z; Huang J
Front Cell Infect Microbiol; 2021; 11():691757. PubMed ID: 34277472
[No Abstract] [Full Text] [Related]
11. Docking-Based Virtual Screening Enables Prioritizing Protein Kinase Inhibitors With
Moreira BP; Batista ICA; Tavares NC; Armstrong T; Gava SG; Torres GP; Mourão MM; Falcone FH
Front Cell Infect Microbiol; 2022; 12():913301. PubMed ID: 35865824
[TBL] [Abstract][Full Text] [Related]
12. Proteomic and immunomic analysis of Schistosoma mekongi egg proteins.
Thiangtrongjit T; Adisakwattana P; Limpanont Y; Dekumyoy P; Nuamtanong S; Chusongsang P; Chusongsang Y; Reamtong O
Exp Parasitol; 2018 Aug; 191():88-96. PubMed ID: 30009810
[TBL] [Abstract][Full Text] [Related]
13. An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans.
Guzman MA; Rugel AR; Tarpley RS; Alwan SN; Chevalier FD; Kovalskyy DP; Cao X; Holloway SP; Anderson TJC; Taylor AB; McHardy SF; LoVerde PT
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008517. PubMed ID: 32810153
[TBL] [Abstract][Full Text] [Related]
14. PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?
Aruleba RT; Adekiya TA; Oyinloye BE; Masamba P; Mbatha LS; Pretorius A; Kappo AP
Infect Disord Drug Targets; 2019; 19(4):337-349. PubMed ID: 30599112
[TBL] [Abstract][Full Text] [Related]
15. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
17. Schistosome transcriptomes: new insights into the parasite and schistosomiasis.
Hu W; Brindley PJ; McManus DP; Feng Z; Han ZG
Trends Mol Med; 2004 May; 10(5):217-25. PubMed ID: 15121048
[TBL] [Abstract][Full Text] [Related]
18. Effect of Praziquantel on
Chienwichai P; Ampawong S; Adisakwattana P; Thiangtrongjit T; Limpanont Y; Chusongsang P; Chusongsang Y; Reamtong O
Pathogens; 2020 May; 9(6):. PubMed ID: 32471184
[No Abstract] [Full Text] [Related]
19. Molecular characterization and functional analysis of the Schistosoma mekongi Ca
Chaimon S; Limpanont Y; Reamtong O; Ampawong S; Phuphisut O; Chusongsang P; Ruangsittichai J; Boonyuen U; Watthanakulpanich D; O'Donoghue AJ; Caffrey CR; Adisakwattana P
Parasit Vectors; 2019 Jul; 12(1):383. PubMed ID: 31362766
[TBL] [Abstract][Full Text] [Related]
20. Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis.
Pereira Moreira B; Weber MHW; Haeberlein S; Mokosch AS; Spengler B; Grevelding CG; Falcone FH
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
